Phase 2CompletedAge-related condition

Preventing Medication Mismanagement in People Living With Dementia Through Automated Medication Dispensing With Facial Recognition and Video Observation

Sponsor
HiDO Technologies (Industry)
Enrolment
50 enrolled
Conditions
Alzheimer Disease; Dementia; Medication Adherence; Type 2 Diabetes Mellitus (T2DM)
Interventions
HiDO-ALZ
Ages
older adults
Registry
NCT06691256

Full record on ClinicalTrials.gov

From the registry

Globally, \>47M individuals live with dementia, with new incidence of 7.7M annually. Medication mismanagement is one of the most common and concerning risk factors in people with dementia (PwD), as it leads to undertreatment, emergency room visits, hospital admissions/readmissions, and serious adverse events. 3M older U.S. adults are admitted to nursing homes due to drug-related adherence problems with costs \>$14B/year. Furthermore, 30% of hospital admissions of older adults are drug related with 11% attributed to medication non-adherence and 17% to adverse drug reactions. While Alzheimer's disease (AD) \& type 2 diabetes mellitus (DM) individually have considerable morbidity \& mortality, they often occur together, worsening adverse outcomes, quality of life, \& care costs. This is especially true as the AD/DM combination creates a complex balancing act of med management \& symptom monitoring in older populations. While the goal is to keep older adults with dementia at home as long as possible, these challenges lead to untold personal \& family suffering, as well as billions in…

Primary outcomes

  • Medication adherence: Percentage of Doses Taken as Prescribed Over 12 Months
  • Change in Health Biomarker: Change in Glucose Levels (mg/dL) Over 12 Months
  • Change in Health Biomarker: Change in HbA1c Levels (%) Over 12 Months
  • Change in Health Biomarker: Change in Creatinine Levels (mg/dL) Over 12 Months

History

  1. Last registry update

  2. Primary completion

  3. Registered

  4. Started